Jakub Klimes active positions
Companies | Position | Start | End |
---|---|---|---|
HealthMode, Inc.
HealthMode, Inc. Packaged SoftwareTechnology Services Part of Mind Medicine (MindMed), Inc., HealthMode, Inc. drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. The company is based in San Francisco, CA. HealthMode's measurement techniques improve understanding of phenotype, streamline and provide assurance for screening and eligibility, provide early detection and mitigation of adverse events, and serve as sensitive, specific, objective, and low participant burden efficacy endpoints. These measurements allow for meaningful integration of clinical trial data with real-world evidence, and provide the basis for movement toward patient-specific measures. Better measurement tools and the platforms to support them help HealthMode's partners make data-informed decisions, reduce uncertainty around enrollment and outcomes, de-risk development, and increase the speed at which novel therapeutics reach patients in need. The company was founded by Bradford Cross, Daniel R. Karlin. HealthMode was acquired by Mind Medicine (MindMed), Inc. on February 26, 2021 for $41.54 million. | Chief Operating Officer | 2019-04-30 | - |
Career history of Jakub Klimes
Statistics
International
United States | 2 |
Operational
Chief Operating Officer | 1 |
Sectoral
Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
HealthMode, Inc.
HealthMode, Inc. Packaged SoftwareTechnology Services Part of Mind Medicine (MindMed), Inc., HealthMode, Inc. drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. The company is based in San Francisco, CA. HealthMode's measurement techniques improve understanding of phenotype, streamline and provide assurance for screening and eligibility, provide early detection and mitigation of adverse events, and serve as sensitive, specific, objective, and low participant burden efficacy endpoints. These measurements allow for meaningful integration of clinical trial data with real-world evidence, and provide the basis for movement toward patient-specific measures. Better measurement tools and the platforms to support them help HealthMode's partners make data-informed decisions, reduce uncertainty around enrollment and outcomes, de-risk development, and increase the speed at which novel therapeutics reach patients in need. The company was founded by Bradford Cross, Daniel R. Karlin. HealthMode was acquired by Mind Medicine (MindMed), Inc. on February 26, 2021 for $41.54 million. | Technology Services |
- Stock Market
- Insiders
- Jakub Klimes
- Experience